DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,054 filers reported holding DANAHER CORPORATION in Q4 2021. The put-call ratio across all filers is 1.38 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $201,693 | -0.6% | 812,952 | -3.8% | 5.17% | +9.1% |
| Q2 2023 | $202,847 | -4.9% | 845,197 | -0.2% | 4.74% | -9.4% |
| Q1 2023 | $213,367 | -4.6% | 846,561 | +0.4% | 5.23% | -16.4% |
| Q4 2022 | $223,748 | -99.9% | 842,997 | -0.3% | 6.25% | +2.0% |
| Q3 2022 | $218,423,000 | -3.7% | 845,651 | -5.5% | 6.12% | -2.6% |
| Q2 2022 | $226,862,000 | -11.0% | 894,850 | +3.0% | 6.29% | +5.4% |
| Q1 2022 | $254,911,000 | -4.3% | 869,026 | +7.3% | 5.96% | +8.7% |
| Q4 2021 | $266,437,000 | -4.8% | 809,815 | -11.9% | 5.48% | -14.8% |
| Q3 2021 | $279,737,000 | +12.3% | 918,859 | -1.0% | 6.44% | +13.6% |
| Q2 2021 | $249,061,000 | +25.2% | 928,087 | +5.0% | 5.66% | +11.4% |
| Q1 2021 | $198,976,000 | +27.6% | 884,022 | +25.9% | 5.08% | +12.8% |
| Q4 2020 | $155,980,000 | +28.2% | 702,170 | +24.3% | 4.51% | -11.3% |
| Q3 2020 | $121,652,000 | +25.0% | 564,956 | +2.7% | 5.08% | +6.7% |
| Q2 2020 | $97,311,000 | +23.6% | 550,311 | -3.3% | 4.76% | +2.6% |
| Q1 2020 | $78,746,000 | -11.3% | 568,933 | -1.7% | 4.64% | +3.2% |
| Q4 2019 | $88,796,000 | +8.0% | 578,551 | +1.7% | 4.50% | -1.5% |
| Q3 2019 | $82,201,000 | -0.1% | 569,144 | -1.2% | 4.56% | -6.4% |
| Q2 2019 | $82,324,000 | +6.7% | 576,013 | -1.4% | 4.87% | +1.6% |
| Q1 2019 | $77,154,000 | +45.6% | 584,413 | +13.7% | 4.80% | +13.3% |
| Q4 2018 | $52,993,000 | -0.1% | 513,900 | +5.3% | 4.24% | +6.6% |
| Q3 2018 | $53,034,000 | +14.7% | 488,070 | +4.2% | 3.97% | +8.6% |
| Q2 2018 | $46,226,000 | +7.3% | 468,445 | +6.4% | 3.66% | -1.2% |
| Q1 2018 | $43,099,000 | -0.3% | 440,190 | -5.5% | 3.70% | +0.8% |
| Q4 2017 | $43,223,000 | +13.5% | 465,665 | +4.9% | 3.67% | +5.5% |
| Q3 2017 | $38,074,000 | +3.1% | 443,856 | +1.5% | 3.48% | -2.5% |
| Q2 2017 | $36,915,000 | -1.3% | 437,434 | +0.0% | 3.57% | -8.6% |
| Q1 2017 | $37,403,000 | +18.2% | 437,308 | +7.6% | 3.91% | +5.4% |
| Q4 2016 | $31,643,000 | -3.2% | 406,515 | -2.6% | 3.71% | +2.5% |
| Q3 2016 | $32,704,000 | – | 417,194 | – | 3.62% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |